
News|Articles|December 26, 2023
Continuing Medical Education 2023
Author(s)Erin O'Brien
Reviewing a year of CMEs in Psychiatric Times®
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
DT120 (Lysergide) ODT Receives Breakthrough Therapy Designation for Treatment of MDD
2
New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial: The Power of Another COMP360 Dose
3
The Postmodern Worldview and Contemporary Psychiatry
4
New Phase 3 Data on Oveporexton for Narcolepsy Type 1
5











